Skip to main content
. Author manuscript; available in PMC: 2010 Sep 13.
Published in final edited form as: Int J Cancer. 2008 May 1;122(9):2077–2084. doi: 10.1002/ijc.23357

Table V.

Association between cutaneous melanoma risk and VDR TaqI, BsmI, and VDR FokI genotypes, stratified by risk factors, in non-Hispanic whites, Texas, 1994–2006

Variable FokI Ff+ff (no. cases/no. controls) FokI FF (no. cases/no. controls)
TaqI BsmI TaqI BsmI

TT Tt+tt Odds ratio CI p§ bb Bb+BB Odds ratio CI p§ TT Tt+tt Odds ratio CI p§ bb Bb+BB Odds ratio CI p§
Age (years) 0.03 0.01 0.80 0.71
 ≤50 39/55 75/78 1.35 0.80, 2.27 35/51 79/82 1.40 0.82–2.38 87/56 117/121 0.62 0.41, 0.95 85/58 119/119 0.68 0.45, 1.04
 >50 80/62 93/149 0.50 0.33, 0.76 71/60 102/151 0.58 0.38–0.89 124/96 190/224 0.66 0.48, 1.92 114/96 200/224 0.76 0.54, 1.05
Sex 0.18 0.17 0.19 0.05
 Male 78/73 104/157 0.62 0.41, 0.93 69/68 113/162 0.69 0.46–1.04 132/108 200/227 0.74 0.54, 1.02 121/111 211/224 0.89 0.64, 1.22
 Female 41/44 64/70 1.00 0.58, 1.72 37/43 68/71 1.11 0.64–1.93 79/44 107/118 0.50 0.32, 0.79 78/43 108/119 0.50 0.32, 0.78
Skin color 0.07 0.65 0.70
 Black or brown 55/43 72/86 0.66 0.39, 1.09 54/38 68/71 0.55 0.32–0.92 82/61 119/157 0.55 0.36, 0.83 74/64 127/154 0.70 0.47, 1.06
 Fair 55/53 81/109 0.74 0.45, 1.19 44/54 73–91 1.08 0.66–1.77 104/62 164/150 0.65 0.44, 0.96 104/61 164/151 0.65 0.44, 0.96
Hair color 0.45 0.81 0.05 0.03
 Black or brown 70/77 105/55 0.76 0.51, 1.15 64/73 111/159 0.81 0.53, 1.22 124/92 184/255 0.54 0.39, 0.75 119/93 189/254 0.58 0.42, 0.81
 Blond(e) or red 40/18 48/39 0.57 0.28, 1.14 34/18 54/39 0.73 0.36, 1.50 62/31 99/49 1.04 0.60, 1.82 59/32 102/48 1.20 0.69, 2.09
Eye color 0.12 0.26 0.38 0.44
 Other 63/77 93/144 0.79 0.52, 1.21 57/73 99/148 0.86 0.56, 1.33 63/46 93/60 0.55 0.39, 0.79 106/90 162/233 0.62 0.44, 0.87
 Blue 46/17 60/51 0.42 0.21, 0.82 40/17 66/51 0.53 0.27, 1.04 77/17 144/51 0.73 0.45, 1.20 72/35 129/81 0.79 0.48, 1.29
Tanning ability 0.44 0.05 0.74 0.83
 Good (high) 30/31 41/75 0.55 0.29, 1.05 31/28 40/78 0.43 0.22, 0.83 40/48 62/113 0.67 0.40, 1.14 40/50 62/111 0.71 0.42, 1.20
 Poor (low) 80/65 112/119 0.77 0.51, 1.17 67/64 125/120 1.00 0.65, 1.53 146/75 221/193 0.60 0.42, 0.84 138/75 229/193 0.66 0.47, 0.92
Lifetime sunburn with blistering 0.83 0.92 0.42 0.93
 None 34/38 49/84 0.63 0.35, 1.14 31/38 52/84 0.73 0.40, 1.32 38/50 70/124 0.75 0.45, 1.25 39/48 69/126 0.68 0.40, 1.14
 ≥1 74/156 105/111 0.71 0.45, 1.10 65/52 114/115 0.79 0.50, 1.23 146/173 208/181 0.58 0.41, 0.82 137/77 217/177 0.70 0.49, 0.98
Freckling in the sun as a child 0.45 0.71 0.10 0.23
 No 62/56 71/109 0.57 0.35, 0.91 54/54 79/111 0.69 0.42, 1.11 83/83 127/173 0.74 0.50, 1.08 80/82 130/174 0.77 0.53, 1.13
 Yes 48/39 81/85 0.77 0.45, 1.30 44/37 85/87 0.81 0.47, 1.38 102/40 154/133 0.46 0.30, 0.71 98/43 158/130 0.55 0.36, 0.84
Moles 0.94 0.67 0.35 0.65
 No 25/30 43/71 0.73 0.38, 1.41 21/30 47/71 0.98 0.50, 1.92 40/47 67/141 0.57 0.34, 0.95 39/53 68/135 0.70 0.42, 1.16
 Yes 94/87 125/156 0.76 0.52, 1.11 85/81 134/162 0.81 0.55, 1.19 171/105 240/204 0.74 0.54, 1.01 160/101 251/208 0.79 0.57, 1.07
Dysplastic nevi 0.98 0.51 0.28 0.24
 No 113/115 155/227 0.70 0.50, 0.97 100/110 168/232 0.80 0.57, 1.12 190/151 282/339 0.66 0.51, 0.86 178/153 294/337 0.75 0.57, 0.98
 Yes 6/2 13/0 NC 6/1 13/1 0.48 0.01, 40.2 21/1 25/6 0.07 0.01, 0.99 21/1 25/6 0.07 0.01, 0.98
First-degree relatives with any cancer 0.36 0.94 0.49 0.63
 No 43/67 67/122 0.86 0.53, 1.40 42/62 68/127 0.79 0.48, 1.29 104/77 129/165 0.58 0.40, 0.85 96/77 137/165 0.68 0.46, 0.99
 Yes 76/50 101/105 0.64 0.41, 1.00 64/49 113/106 0.83 0.52, 1.31 107/75 178/180 0.70 0.49, 1.00 103/77 182/178 0.77 0.53, 1.10
*

The numbers of subjects in some of the strata were less than the total number of subjects included in this study because some subjects did not provide the information.

CI, confidence interval.

Odds ratios were adjusted for age and sex in a logistic regression model.

§

p values for interaction were obtained from logistic regression models after adjustment for age, sex, and the main effects of the interactive variables.

HHS Vulnerability Disclosure